Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger

26th March 2020 Uncategorised 0

With the novel coronavirus pandemic continuing to hamstring operations, U.S. regulators have warned that major corporate transaction reviews could be held up. Now, thanks to those COVID-19 delays, a generics megamerger between Pfizer’s Upjohn and Mylan has been postponed until the back half of the year.

More: Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Source: fierce